182 related articles for article (PubMed ID: 31748270)
21. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.
Qian J; Wang Q; Dose M; Pruett N; Kieffer-Kwon KR; Resch W; Liang G; Tang Z; Mathé E; Benner C; Dubois W; Nelson S; Vian L; Oliveira TY; Jankovic M; Hakim O; Gazumyan A; Pavri R; Awasthi P; Song B; Liu G; Chen L; Zhu S; Feigenbaum L; Staudt L; Murre C; Ruan Y; Robbiani DF; Pan-Hammarström Q; Nussenzweig MC; Casellas R
Cell; 2014 Dec; 159(7):1524-37. PubMed ID: 25483777
[TBL] [Abstract][Full Text] [Related]
22. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
[TBL] [Abstract][Full Text] [Related]
23. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
24. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas.
Baron BW; Zeleznik-Le N; Baron MJ; Theisler C; Huo D; Krasowski MD; Thirman MJ; Baron RM; Baron JM
Proc Natl Acad Sci U S A; 2007 May; 104(18):7449-54. PubMed ID: 17468402
[TBL] [Abstract][Full Text] [Related]
25. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
Jardin F; Ruminy P; Bastard C; Tilly H
Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
[TBL] [Abstract][Full Text] [Related]
26. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
[TBL] [Abstract][Full Text] [Related]
27. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.
Basso K; Dalla-Favera R
Adv Immunol; 2010; 105():193-210. PubMed ID: 20510734
[TBL] [Abstract][Full Text] [Related]
28. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
[TBL] [Abstract][Full Text] [Related]
30. Targeting HDAC3 in CREBBP-Mutant Lymphomas Counterstrikes Unopposed Enhancer Deacetylation of B-cell Signaling and Immune Response Genes.
Höpken UE
Cancer Discov; 2017 Jan; 7(1):14-16. PubMed ID: 28062671
[TBL] [Abstract][Full Text] [Related]
31. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype.
Smit LA; Bende RJ; Aten J; Guikema JE; Aarts WM; van Noesel CJ
Cancer Res; 2003 Jul; 63(14):3894-8. PubMed ID: 12873980
[TBL] [Abstract][Full Text] [Related]
32. High levels of AID cause strand bias of mutations at A versus T in Burkitt's lymphoma cells.
Kano C; Wang JY
Mol Immunol; 2013 Jul; 54(3-4):397-402. PubMed ID: 23399385
[TBL] [Abstract][Full Text] [Related]
33. Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma.
Jardin F; Ruminy P; Parmentier F; Picquenot JM; Courel MN; Bertrand P; Buchonnet G; Tilly H; Bastard C
Leukemia; 2005 Oct; 19(10):1824-30. PubMed ID: 16094416
[TBL] [Abstract][Full Text] [Related]
34. Single-cell whole-genome sequencing reveals the functional landscape of somatic mutations in B lymphocytes across the human lifespan.
Zhang L; Dong X; Lee M; Maslov AY; Wang T; Vijg J
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9014-9019. PubMed ID: 30992375
[TBL] [Abstract][Full Text] [Related]
35. TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations.
Gebauer N; Bernard V; Gebauer W; Thorns C; Feller AC; Merz H
Leuk Lymphoma; 2015 Jan; 56(1):179-85. PubMed ID: 24679006
[TBL] [Abstract][Full Text] [Related]
36. Targeting of somatic hypermutation.
Odegard VH; Schatz DG
Nat Rev Immunol; 2006 Aug; 6(8):573-83. PubMed ID: 16868548
[TBL] [Abstract][Full Text] [Related]
37. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.
Walker SR; Nelson EA; Frank DA
Oncogene; 2007 Jan; 26(2):224-33. PubMed ID: 16819511
[TBL] [Abstract][Full Text] [Related]
38. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
Steele EJ
DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
[TBL] [Abstract][Full Text] [Related]
39. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV
Burns A; Alsolami R; Becq J; Stamatopoulos B; Timbs A; Bruce D; Robbe P; Vavoulis D; Clifford R; Cabes M; Dreau H; Taylor J; Knight SJL; Mansson R; Bentley D; Beekman R; Martín-Subero JI; Campo E; Houlston RS; Ridout KE; Schuh A
Leukemia; 2018 Feb; 32(2):332-342. PubMed ID: 28584254
[TBL] [Abstract][Full Text] [Related]
40. B cells in chronically hepatitis C virus-infected individuals lack a virus-induced mutation signature in the TP53, CTNNB1, and BCL6 genes.
Tucci FA; Broering R; Johansson P; Schlaak JF; Küppers R
J Virol; 2013 Mar; 87(5):2956-62. PubMed ID: 23269799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
